Back to results
US 8,012,932 B2Granted
Contraceptives based on SP22 and SP22 antibodies
AssigneeU.S. Environmental Protection Agency
InventorGary R. Klinefelter
Life of this patent
Estimating the term…
Abstract
Oral, topical and injectable contraceptives, which are based on sperm protein 22 kDa (SP22) polypeptides and antibodies and infertility diagnostics are provided.
Claims11
A contraceptive vaccine comprising the SP22 polypeptide of SEQ ID NO:
- 2 or a fragment thereof, wherein the fragment comprises a sequence selected from the group consisting of amino acids 34-48 of SEQ ID NO:
- 2, amino acids 43-57 of SEQ ID NO:
- 2, amino acids 47-102 of SEQ ID NO:
- 2, amino acids 88-102 of SEQ ID NO:
- 2, amino acids 118-132 of SEQ ID NO:
- 2, amino acids 136-150 of SEQ ID NO:
- 2, and amino acids 160-174 of SEQ ID NO:
- 2, and a pharmaceutically acceptable carrier.
5 more elements
Dependencies are inferred from the claim text.